Lv2
116 积分 2025-09-24 加入
suibian
Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future
2个月前
已完结
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
2个月前
已完结
Adipokines: masterminds of metabolic inflammation
2个月前
已完结
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
2个月前
已完结
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
2个月前
已完结
White adipocyte dysfunction and obesity-associated pathologies in humans
3个月前
已完结
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
3个月前
已完结
Non-caloric sweetener effects on brain appetite regulation in individuals across varying body weights
3个月前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
3个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
3个月前
已完结
皖公网安备34019202002308
